Urology

Phytotherapy in the treatment of benign prostatic hyperplasia: an update - I bis II nach Alken)
pp. 671-678(8)
Authors: Lowe F.C.; Fagelman E.

Pheochromocytomas: can malignant potential be predicted? - effective treatment with a combination of cyclophosphamide, vincristine, and dacarabazine
pp. 679-683(5)
Authors: John H.; Ziegler W.H.; Hauri D.; Jaeger P.

Tubular dysplasia and carcinoma in situ: precursors of renal cell carcinoma - a morphologic and histochemical study of 100 orchiectomy specimens with invasive germ cell tumors
pp. 684-689(6)
Authors: Yorukoglu K.; Aktas S.; Mungan M.U.; Kirkali Z.

Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years - how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?
pp. 690-695(6)
Authors: Hudson P.B.; Boake R.; Trachtenberg J.; Romas N.A.; Rosenblatt S.; Narayan P.; Geller J.; Lieber M.M.; Elhilali M.; Norman R.; Patterson L.; Perreault J.-P.; Malek G.H.; Bruskewitz R.C.; Roy J.B.; Ko A.; Jacobsen C.A.; Stoner E.

Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? - results of a randomized, double-blind, placebo-controlled clinical trial
pp. 696-700(5)
Authors: Yang X.J.; Lecksell K.; Short K.; Gottesman J.; Peterson L.; Bannow J.; Schellhammer P.F.; Fitch W.P.; Hodge G.B.; Parra R.; Rouse S.; Waldstreicher J.; Epstein J.I.

Heritability of the symptoms of benign prostatic hyperplasia and the roles of age and zonal prostate volumes in twins - how bothersome are they?
pp. 701-706(6)
Authors: Meikle A.W.; Bansal A.; Murray D.K.; Stephenson R.A.; Middleton R.G.

E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens - identification of three independent regions
pp. 707-713(7)
Authors: De Marzo A.M.; Knudsen B.; Chan-Tack K.; Epstein J.I.

Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer 1
pp. 714-721(8)
Authors: Gao C.-L.; Maheshwari S.; Dean R.C.; Tatum L.; Mooneyhan R.; Connelly R.R.; McLeod D.G.; Srivastava S.; Moul J.W.

Serum half-life time determination of free and total prostate-specific antigen following radical prostatectomy-a critical assessment - the problem of interpretation in sequential studies
pp. 722-730(9)
Authors: Brandle E.; Hautmann O.; Bachem M.; Kleinschmidt K.; Gottfried H.W.; Grunert A.; Hautmann R.E.

Kinetics of postbiopsy levels of serum free prostate-specific antigen and percent free prostate-specific antigen - studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin
pp. 731-735(5)
Authors: Lechevallier E.; Eghazarian C.; Ortega J.-C.; Daniel L.; Roux F.; Thirion X.; Coulange C.

Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations - influence of total PSA, prostate volume and age
pp. 736-745(10)
Authors: Veltri R.W.; Miller M.C.

Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1 - a quantitative assessment
pp. 746-751(6)
Authors: Finlay J.A.; Day J.R.; Rittenhouse H.G.

Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy - correlation between ultrasound determined tumor contact length and pathologically confirmed extraprostatic extension
pp. 752-756(5)
Authors: Holmes G.F.; Walsh P.C.; Pound C.R.; Epstein J.I.

CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results - role of bone stromal cells
pp. 757-763(7)
Authors: Klotz L.H.; Goldenberg S.L.; Jewett M.; Barkin J.; Chetner M.; Fradet Y.; Chin J.; Laplante S.

Prostate cancer detection: relationship to prostate size - predictive value for cancer
pp. 764-768(5)
Authors: Chen M.E.; Troncoso P.; Johnston D.; Tang K.; Babaian R.J.

Prostate cancer histologic trends in the metropolitan Detroit area, 1982 to 1996 - interobserver reproducibility of five different grading systems
pp. 769-774(6)
Authors: Schwartz K.L.; Grignon D.J.; Sakr W.A.; Wood D.P.

Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate - an orally active type 5 cyclic GMP specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
pp. 775-778(4)
Authors: Zelefsky M.J.; Mckee A.B.; Lee H.; Leibel S.A.

Venous malformation of the glans penis: efficacy of treatment with neodymium:yttrium-aluminum-garnet laser - a rare benign genital tumor of childhood
pp. 779-783(5)
Authors: Clemente Ramos L.M.; Maganto Pavon E.; Escudero Barrilero A.

Iatrogenic prostatic urethral strictures: classification and endoscopic treatment - long-term followup and comparison with transpubic urethroplasty
pp. 784-789(6)
Authors: Pansadoro V.; Emiliozzi P.

Iontophoresis as a new method of delivering local anesthesia to the urethra: a pilot study - a preliminary experience
pp. 790-792(3)
Authors: Gorton E.; Stanton S.

EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction 1
pp. 793-799(7)
Authors: Althof S.E.; Corty E.W.; Levine S.B.; Levine F.; Burnett A.L.; McVary K.; Stecher V.; Seftel A.D.

Sildenafil citrate (viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects - analysis of results and complications
pp. 800-805(6)
Authors: Dinsmore W.W.; Hodges M.; Hargreaves C.; Osterloh I.H.; Smith M.D.; Rosen R.C.

Increased incidence of testicular cancer in active duty members of the Department of Defense1
pp. 806-807(2)
Authors: Thompson I.M.; Optenberg S.; Byers R.; Dove M.

Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors - the Indiana University experience (1965-1989)
pp. 808-811(4)
Authors: Albers P.; Bender H.; Yilmaz H.; Schoeneich G.; Biersack H.-J.; Mueller S.C.

Contemporary incidence of morbidity related to vesicoureteral reflux - clinical characteristics
pp. 812-815(4)
Authors: Vallee J.P.; Vallee M.P.D.; Greenfield S.P.; Wan J.; Springate J.

Preliminary results of percutaneous treatment of renal cysts with povidone-iodine sclerosis - percutaneous treatment with povidone-iodine sclerosis
pp. 816-817(2)
Authors: Phelan M.; Zajko A.; Hrebinko R.L.

Magnetic resonance imaging of a ''saddle bag'' urethral diverticulum - value of MR imaging
pp. 818-819(2)
Authors: Blander D.S.; Broderick G.A.; Rovner E.S.

Scrotal lymphangioma in an adult - the misdiagnosed scrotal mass
pp. 820-821(2)
Authors: Kingsly K.A.; Sant G.R.

Perineal approach to radical prostatectomy in kidney transplant recipients with localized prostate cancer - la voie perineale est-elle la voie elective de la prostatectomie radicale?
pp. 822-824(3)
Authors: Yiou R.; Salomon L.; Colombel M.; Patard J.-J.; Chopin D.; Abbou C.-C.

Hydronephrosis in pregnancy: simultaneous depiction of fetal and maternal hydronephrosis by magnetic resonance urography
pp. 825-827(3)
Authors: Fradin J.M.; Regan F.; Rodriquez R.; Moore R.

Interstitial microwave thermoablation for localized prostate cancer1
pp. 828-831(4)
Authors: Lancaster C.; Toi A.; Trachtenberg J.

Adenosquamous carcinoma of the prostate: case report with DNA analysis, immunohistochemistry, and literature review - clinicopathologic implications
pp. 832-834(3)
Authors: Bassler T.J.; Orozco R.; Bassler I.C.; Boyle L.M.; Bormes T.

Now what do we do with all these genes? Yeast-based two-hybrid analysis: an emerging technology for molecular urology in the post-genome era - a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma
pp. 835-842(8)
Authors: Gaston S.M.; Loughlin K.R.

Expression of MAGE genes in testicular germ cell tumors
pp. 843-847(5)
Authors: Hara I.; Hara S.; Miyake H.; Yamanaka K.; Nagai H.; Gohji K.; Arakawa S.; Kamidono S.

Endogenous carbohydrate-binding proteins of rabbit and human bladder - structural features and epitope characterization
pp. 848-852(5)
Authors: Puch S.; Bhavanandan V.P.

Near-infrared confocal laser scanning microscopy of bladder tissue in vivo - a scanning electron microscopic study
pp. 853-857(5)
Authors: Koenig F.; Gonzalez S.; White W.M.; Lein M.; Rajadhyaksha M.